Alpha-Maven Cannabis Investment Dashboard:

Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1mo ago Cannabis greenmarketreport Views: 233

Irwin Naturals Inc. (CSE: IWIN), formerly Datinvest International Ltd. closed on its previously announced reverse takeover of Datinvest International Ltd. by Irwin Naturals. The company de-listed its common shares from the NEX Board of the TSX Venture Exchange effective at the close of business on August 13, 2021. It began trading its subordinate voting shares on the Canadian Securities Exchange (“CSE”) under the ticker “IWIN” on August 17, 2021. Irwin Naturals is a leading herbal supplement company in the United States and is a large distributor of CBD products in mass-market and health food chain stores. The Irwin brand has been a household name for the better part of 27-years and its herbal supplements are distributed in about 100,000 stores. In 2018, Irwin became one of the first legacy supplement brands to launch a line of full-spectrum Hemp extract CBD products. Irwin’s initial product launched into the space was Irwin Naturals CBD soft-gels. Irwin continues to expand the CBD products within the Irwin Naturals’ brand more recently adding CBD topical products in the form of balms, roll-ons, gels and creams. At present, Irwin contracts with third-party manufacturers in Kentucky, Oregon, Texas, Florida, Illinois, and California to produce Hemp-derived products. At this time though, Irwin Naturals derives the majority of its revenue from non-hemp related products. In connection with the closing of the Business Combination, Irwin named a new leadership team as follows: Klee Irwin – Chairman, Chief Executive Officer and Director Philippe Faraut – Chief Financial Officer, Corporate Secretary and Director Marc-David Bismuth – Director Rod Kight, Esq. – Director Terms In connection with Business Combination, the Company effected a consolidation (the “Consolidation”) of the common shares of the Company (the “Common Shares”) on a one post-Consolidation Common Share for every 8.31617 pre-Consolidation Common Shares basis. In addition, the Company amended its articles to: (i) create the proportionate voting shares and multiple voting shares (the “Multiple Voting Shares”); (ii) to add special rights and restrictions to the Common Shares and change the identifying name of the Common Shares to “Subordinate Voting Shares”; and (iii) to change its name from “Datinvest International Ltd.” to “Irwin Naturals Inc.” Shareholder approval for certain of these matters where required was obtained at an annual and special meeting of the Company’s shareholders held on June 24, 2021. Irwin Naturals Begins Trading On CSE on Green Market Report. -

Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.